The case involves Farmasino Co. Ltd. as the Operational Creditor/Applicant and Dalas Biotech Ltd. as the Corporate Debtor/Respondent. The matter was brought before the National Company Law Tribunal (NCLT), Jaipur Bench, under Section 9 of the Insolvency and Bankruptcy Code (IBC), 2016. The Operational Creditor initiated proceedings against the Corporate Debtor.
Farmasino Co. Ltd., the Operational Creditor, filed a case against Dalas Biotech Ltd., the Corporate Debtor, under Section 9 of the IBC, 2016. During the proceedings, both parties informed the court that they had reached a settlement, executing consent terms (Annexure-A). The Operational Creditor then requested to withdraw the application. The court noted that the name of the Operational Creditor had changed from Farmasino Pharmaceuticals (Jiangsu) Co. Ltd. to Farmasino Co. Ltd. An amended memo of parties was submitted as Annexure-C.
Sign in to view the parties.
Corporate Insolvency Resolution Process…
Settlement reached…
The case involves Farmasino Co. Ltd. as the Operational Creditor/Applicant and Dalas Biotech Ltd. as the Corporate Debtor/Respondent. The matter was brought before the National Company Law Tribunal (NCLT), Jaipur Bench, under Section 9 of the Insolvency and Bankruptcy Code (IBC), 2016. The Operational Creditor initiated proceedings against the Corporate Debtor.
Farmasino Co. Ltd., the Operational Creditor, filed a case against Dalas Biotech Ltd., the Corporate Debtor, under Section 9 of the IBC, 2016. During the proceedings, both parties informed the court that they had reached a settlement, executing consent terms (Annexure-A). The Operational Creditor then requested to withdraw the application. The court noted that the name of the Operational Creditor had changed from Farmasino Pharmaceuticals (Jiangsu) Co. Ltd. to Farmasino Co. Ltd. An amended memo of parties was submitted as Annexure-C.
Corporate Insolvency Resolution Process…
Settlement reached…